Medinet News

Medinet: Notice regarding the recording of special profit (profit from sale of investment securities)

Jan 5 23:15 ET

Medinet: Extraordinary Report

Dec 25, 2024 22:04 ET

Medinet: Notice regarding changes in representative directors

Dec 18, 2024 03:00 ET

Medinet: Confirmation

Dec 18, 2024 01:40 ET

Medinet: Internal Control Report - 29th Period (2023/10/01 - 2024/09/30)

Dec 18, 2024 01:38 ET

Medinet: Financial Report - 29th Term (2023/10/01 - 2024/09/30)

Dec 18, 2024 01:35 ET

Medinet: Financial results briefing materials for the fiscal year ending 2024/9

Nov 28, 2024 01:30 ET

Medinet: Convocation materials for the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9 (matters not described in issuance documents)

Nov 25, 2024 18:00 ET

Medinet: Notice of Convocation of the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9

Nov 25, 2024 18:00 ET

Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates

Nov 22, 2024 01:30 ET

Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds

Nov 22, 2024 01:30 ET

Medinet: Notice regarding the recording of non-operating income and extraordinary losses

Nov 13, 2024 01:30 ET

Medinet: Summary of Financial Results 2024

Nov 13, 2024 01:30 ET

Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

Nov 13, 2024 01:30 ET

Medinet: Explanatory materials on business plans and growth potential

Nov 13, 2024 01:30 ET

Medinet: (Changes in disclosure matters) Changes in the use of funds and planned expenditure periods relating to the issuance of stock acquisition rights through third-party allotment

Nov 8, 2024 01:30 ET

Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure

Nov 8, 2024 01:30 ET

Medinet: (Changes in disclosure matters) Changes in the planned expenditure period relating to the issuance of stock acquisition rights through third-party allotment

Sep 27, 2024 04:00 ET

Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Sep 11, 2024 03:00 ET

Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business

Sep 10, 2024 22:00 ET